GlassScriptPhysician profile
Sawsan W Jamil
NPI 1790942993
$19,911.66
in general payments reported to CMS, 2019-2025
27 companies · $5,082 in 2025
The $5,082 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $3,411 · 2021: $9,199 · 2022: $486 · 2023: $779 · 2024: $463 · 2025: $5,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,600 · Food and Beverage: $1,449 · Travel and Lodging: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,599.99 |
| Food and Beverage | $1,448.86 |
| Travel and Lodging | $274.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,196.27 | 2020-2025 | |
| Aspira Women'S Health INC | $654.09 | 2019-2024 | Ova1 |
| Astellas Pharma US INC | $363.99 | 2022-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $248.42 | 2022-2025 | Acessa Provu System, Aptima, Coolseal Generator |
| Medtronic, INC. | $171.20 | 2021-2024 | Interstim |
| Organon LLC | $153.07 | 2022-2025 | Nexplanon, Nuvaring |
| Mayne Pharma Commercial LLC | $144.70 | 2023-2025 | |
| Abbvie INC. | $136.21 | 2019-2023 | |
| Coloplast Corp | $126.65 | 2019 | |
| Nevro Corp. | $123.28 | 2019 | |
| Shield Therapeutics INC | $90.98 | 2023-2024 | Accrufer |
| Myriad Women'S Health, INC. | $89.16 | 2023 | Myrisk |
| Biogen, INC. | $76.41 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $46.28 | 2025 | Myfembree |
| Merck Sharp & Dohme LLC | $36.57 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $32.76 | 2019 | |
| Therapeuticsmd, INC. | $32.33 | 2019 | |
| Allergan, INC. | $24.18 | 2019 | |
| Coopersurgical, INC. | $22.04 | 2024 | Endosee |
| Duchesnay USA Incorporated | $21.75 | 2019 | |
| Smith+Nephew, INC. | $21.06 | 2022 | |
| Convatec INC. | $20.44 | 2023 | |
| Gynesonics, INC. | $18.68 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amgen INC. | $17.77 | 2024 | Prolia, Evenity |
| Vertical Pharmaceuticals, LLC | $15.62 | 2020 | |
| Exact Sciences Corporation | $15.07 | 2025 | Cologuard Collection Kit |
| Lupin INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sawsan Jamil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.